These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18727052)

  • 1. Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues.
    Tessem MB; Swanson MG; Keshari KR; Albers MJ; Joun D; Tabatabai ZL; Simko JP; Shinohara K; Nelson SJ; Vigneron DB; Gribbestad IS; Kurhanewicz J
    Magn Reson Med; 2008 Sep; 60(3):510-6. PubMed ID: 18727052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR quantification of lactate production and efflux and glutamate fractional enrichment in living human prostate biopsies cultured with [1,6-
    Bancroft Brown J; Sriram R; VanCriekinge M; Delos Santos R; Sun J; Delos Santos J; Tabatabai ZL; Shinohara K; Nguyen H; Peehl DM; Kurhanewicz J
    Magn Reson Med; 2019 Aug; 82(2):566-576. PubMed ID: 30924180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading.
    Albers MJ; Bok R; Chen AP; Cunningham CH; Zierhut ML; Zhang VY; Kohler SJ; Tropp J; Hurd RE; Yen YF; Nelson SJ; Vigneron DB; Kurhanewicz J
    Cancer Res; 2008 Oct; 68(20):8607-15. PubMed ID: 18922937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy.
    Santos CF; Kurhanewicz J; Tabatabai ZL; Simko JP; Keshari KR; Gbegnon A; Santos RD; Federman S; Shinohara K; Carroll PR; Haqq CM; Swanson MG
    NMR Biomed; 2010 May; 23(4):391-8. PubMed ID: 20033906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy.
    Swanson MG; Zektzer AS; Tabatabai ZL; Simko J; Jarso S; Keshari KR; Schmitt L; Carroll PR; Shinohara K; Vigneron DB; Kurhanewicz J
    Magn Reson Med; 2006 Jun; 55(6):1257-64. PubMed ID: 16685733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsies.
    van Asten JJ; Cuijpers V; Hulsbergen-van de Kaa C; Soede-Huijbregts C; Witjes JA; Verhofstad A; Heerschap A
    MAGMA; 2008 Nov; 21(6):435-42. PubMed ID: 19031091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of metabolic imaging in radiation therapy of prostate cancer.
    Zhang VY; Westphalen A; Delos Santos L; Tabatabai ZL; Shinohara K; Vigneron DB; Kurhanewicz J
    NMR Biomed; 2014 Jan; 27(1):100-11. PubMed ID: 23940096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy.
    Swanson MG; Keshari KR; Tabatabai ZL; Simko JP; Shinohara K; Carroll PR; Zektzer AS; Kurhanewicz J
    Magn Reson Med; 2008 Jul; 60(1):33-40. PubMed ID: 18581409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo (1) H MR spectroscopic imaging of aggressive prostate cancer: can we detect lactate?
    Kobus T; Wright AJ; Van Asten JJ; Heerschap A; Scheenen TW
    Magn Reson Med; 2014 Jan; 71(1):26-34. PubMed ID: 23475759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for metabolic evaluation of prostate cancer cells using proton and (13)C HR-MAS spectroscopy and [3-(13)C] pyruvate as a metabolic substrate.
    Levin YS; Albers MJ; Butler TN; Spielman D; Peehl DM; Kurhanewicz J
    Magn Reson Med; 2009 Nov; 62(5):1091-8. PubMed ID: 19780158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness.
    Giskeødegård GF; Bertilsson H; Selnæs KM; Wright AJ; Bathen TF; Viset T; Halgunset J; Angelsen A; Gribbestad IS; Tessem MB
    PLoS One; 2013; 8(4):e62375. PubMed ID: 23626811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor.
    Keshari KR; Sriram R; Van Criekinge M; Wilson DM; Wang ZJ; Vigneron DB; Peehl DM; Kurhanewicz J
    Prostate; 2013 Aug; 73(11):1171-81. PubMed ID: 23532911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Method of the connection HMRS and TRUS images--improvement of effectiveness transrectal core biopsy of the prostate].
    Lipczyński W
    Przegl Lek; 2012; 69(5):176-80. PubMed ID: 23050412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
    Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
    Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using transrectal 31phosphorus magnetic resonance spectroscopy: a preliminary report.
    Narayan P; Jajodia P; Kurhanewicz J; Thomas A; MacDonald J; Hubesch B; Hedgcock M; Anderson CM; James TL; Tanagho EA
    J Urol; 1991 Jul; 146(1):66-74. PubMed ID: 1711587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis.
    Martin PR; Cool DW; Romagnoli C; Fenster A; Ward AD
    Med Phys; 2014 Jul; 41(7):073504. PubMed ID: 24989418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of High-Resolution Magic Angle Spinning 1H Nuclear Magnetic Resonance Spectroscopy for Predicting the Invasive Component in Patients with Ductal Carcinoma In Situ Diagnosed on Preoperative Biopsy.
    Chae EY; Shin HJ; Kim S; Baek HM; Yoon D; Kim S; Shim YE; Kim HH; Cha JH; Choi WJ; Lee JH; Shin JH; Lee HJ; Gong G
    PLoS One; 2016; 11(8):e0161038. PubMed ID: 27560937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Efficacy of Transrectal Ultrasound Guided Biopsy Versus Transperineal Template Biopsy of the Prostate in Diagnosing Prostate Cancer in Men with Previous Negative Transrectal Ultrasound Guided Biopsy.
    Nafie S; Wanis M; Khan M
    Urol J; 2017 Mar; 14(2):3008-3012. PubMed ID: 28299763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
    Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
    NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.